Advanced Materials | Reshaping De Novo Protein Switches into Bioresponsive Materials for Biomarker, Toxin, and Viral Detection

This study provides a novel strategy for rapid on-site detection of biomarkers without the need for complex equipment, offering direct inspiration for optimizing experimental designs in early disease screening.

 

Literature Overview

This article, titled 'Reshaping de novo protein switches into bioresponsive materials for biomarker, toxin, and viral detection' and published in Advanced Materials, systematically explores the integration of de novo protein switches (lucCage-lucKey) with regenerated silk fibroin (RSF) to construct various morphologically stable and highly sensitive bioresponsive materials.

Background Knowledge

In the early diagnosis of infectious diseases and cancer, traditional detection methods often rely on complex laboratory equipment and cold chain transportation, making them difficult to deploy in resource-limited regions or for point-of-care use. For the detection of key targets such as HER2, existing biosensors face significant bottlenecks in stability, morphological adaptability, and anti-interference capabilities, failing to meet the demands of portable and wearable devices. By introducing silk fibroin as a biocompatible matrix, this study addresses the challenges of protein switch inactivation and conformational restriction in solid-state materials, providing a critical entry point for developing novel sensing interfaces capable of detecting hazardous factors such as SARS-CoV-2 and Botulinum neurotoxin B.

 

 

Research Methods and Core Experiments

The authors mixed regenerated silk fibroin solutions with the lucCage-lucKey protein switch system and employed various techniques, including inkjet printing, freeze-drying, electrospinning, and solution casting, to fabricate multiple material forms such as independent films, porous sponges, medical masks, laboratory gloves, and drone-mounted sensing modules. Experiments verified that these materials retained the conformational change capability of the protein switches after dissolution or direct contact with analytes, outputting detection results via chemiluminescence signals.

Key evidence shows that in complex media simulating saliva, the RSF/Key-Cage hybrid material achieved a detection limit of 10 pM for the RBD protein, exhibiting high specificity for targets such as HER2 and BoNT/B without interference from background molecules. Accelerated aging experiments further demonstrated that the material maintained detection sensitivity at the nanomolar or even picomolar level after storage at 60°C for 4 months or at room temperature for 1 year, confirming its long-term stability under non-cold chain conditions.

Key Conclusions and Perspectives

• It was discovered that the de novo designed lucCage-lucKey protein switch can be successfully embedded into a silk fibroin matrix, maintaining high-sensitivity responses to HER2, RBD, BoNT/B, and anti-HBV in the solid state, with detection limits reaching nanomolar and picomolar levels.
• It was confirmed that inkjet printing and electrospinning processes do not compromise the function of the protein switches, making it possible to directly integrate sensing functions into personal protective equipment such as masks and gloves, providing a new paradigm for point-of-care testing.
• The study revealed that the silk fibroin matrix possesses excellent long-term stability, freeing biosensors from reliance on refrigerated transport and significantly expanding their application potential in disease monitoring in remote areas and environmental monitoring.
• By mounting RSF sponges on drones, remote sampling and detection of SARS-CoV-2 aerosols in the air were successfully achieved, demonstrating the unique advantages of this technology in the field of environmental virus monitoring.

Research Significance and Prospects

This discovery provides a low-cost, high-throughput screening tool for biomarker validation in drug development, particularly in scenarios requiring the simulation of complex body fluid environments. For clinical monitoring, these wearable bioresponsive materials make continuous, non-invasive monitoring of patient HER2 levels or toxin exposure a reality, potentially transforming existing diagnostic and treatment workflows. Furthermore, this study offers new materials science insights for disease modeling, utilizing biopolymer matrices to stabilize dynamic biological elements to construct in vitro models that more closely mimic physiological environments.

 

 

Conclusion

This study successfully combined rational protein design with advanced material processing techniques, breaking the traditional dependence of biosensors on liquid environments and cold chain transportation. By constructing hybrid materials based on silk fibroin and de novo protein switches, researchers not only achieved high-sensitivity and high-specificity detection of key targets such as HER2 and SARS-CoV-2 but also transformed them into everyday accessible forms like masks, gloves, and films. This breakthrough marks a critical step in the transition of biosensing technology from the laboratory to broad application scenarios, laying a solid material foundation for building ubiquitous disease monitoring networks. From precise laboratory detection to immediate on-site clinical response, this study provides a highly promising technical pathway for establishing future personalized medicine and public health security systems, making precise early disease screening possible in resource-limited environments.

 

Luciana d'Amone, Giusy Matzeu, Alfredo Quijano-Rubio, David Baker, and Fiorenzo G Omenetto. Reshaping de novo protein switches into bioresponsive materials for biomarker, toxin, and viral detection. Advanced materials (Deerfield Beach, Fla.).